(Q84798910)

English

Endorectal T2-weighted MRI does not differentiate between favorable and adverse pathologic features in men with prostate cancer who would qualify for active surveillance

scientific article published on 01 May 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21856187%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Endorectal T2-weighted MRI does not differentiate between favorable and adverse pathologic features in men with prostate cancer who would qualify for active surveillance (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21856187%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

9

object named as

Alan J Wein

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21856187%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

author name string

Thomas J Guzzo

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21856187%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Matthew J Resnick

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21856187%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Daniel J Canter

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21856187%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Trinity J Bivalacqua

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21856187%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Mark A Rosen

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21856187%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Meredith R Bergey

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21856187%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Laurie Magerfleisch

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21856187%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

John E Tomazewski

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21856187%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

S Bruce Malkowicz

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21856187%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

publication date

1 May 2012

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21856187%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Urologic Oncology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21856187%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

30

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21856187%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21856187%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

301-305

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21856187%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Prostate-specific antigen and prostate cancer: prediction, detection and monitoring.

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.08.023

7 January 2021

Prostate cancer: epidemiology and health-related quality of life

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.08.023

7 January 2021

Lead times and overdetection due to prostate-specific antigen screening: estimates from the European Randomized Study of Screening for Prostate Cancer.

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.08.023

7 January 2021

Long-term biochemical disease-free and cancer-specific survival following anatomic radical retropubic prostatectomy. The 15-year Johns Hopkins experience

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.08.023

7 January 2021

Long-term results after external beam radiation therapy for T1-T2 localized prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.08.023

7 January 2021

Outcomes for intermediate risk prostate cancer: are there advantages for surgery, external radiation, or brachytherapy?

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.08.023

7 January 2021

Endorectal coil magnetic resonance imaging identifies locally advanced prostate cancer in select patients with clinically localized disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.08.023

7 January 2021

How good is MRI at detecting and characterising cancer within the prostate?

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.08.023

7 January 2021

Expectant management of prostate cancer with curative intent: an update of the Johns Hopkins experience

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.08.023

7 January 2021

Minimal tumor volume may provide additional prognostic information in good performance patients after radical prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.08.023

7 January 2021

Cancer statistics, 2009

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.08.023

7 January 2021

What percentage of patients with newly diagnosed carcinoma of the prostate are candidates for surveillance? An analysis of the CaPSURE database

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.08.023

7 January 2021

Delayed versus immediate surgical intervention and prostate cancer outcome

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.08.023

7 January 2021

Prostate cancer: is inapparent tumor at endorectal MR and MR spectroscopic imaging a favorable prognostic finding in patients who select active surveillance?

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.08.023

7 January 2021

The utility of magnetic resonance imaging and spectroscopy for predicting insignificant prostate cancer: an initial analysis

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.08.023

7 January 2021

Identifiers

10.1016/J.UROLONC.2010.08.023

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21856187%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21856187%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q84798910&oldid=1368859767"